Market Performance Snapshot

Formula (FORTY.TA) closed the day at an impressive 3.57 % gain, reaching ILS 386.1 on the Tel Aviv Stock Exchange. With a circulating supply of 15.3 million shares, the company’s market capitalization now sits at roughly ILS 1.6 billion. In the past 24 hours alone, Formula’s shares exchanged a staggering ILS 993.6 million, underscoring the fierce liquidity that surrounds the stock.

Since the close of the previous month, Formula’s price has rallied 6.89 %. The 200‑day simple moving average is at ILS 38,129.7, a level that remains comfortably below the all‑time high of ILS 58,250 recorded on 12 October 2025. The 52‑week low of ILS 29,620 on 29 June 2026 illustrates a dramatic upward trajectory for the company, hinting that the current rally is part of a broader, sustained trend.

Peer Comparison – 24‑Hour Moves

  • Allot (ALLT) – Down 1.66 %, now trading at USD 8.91. Market cap: USD 446.7 million; P/E: 42.36. Recent Form 6‑K filed after the October 22 shareholders’ meeting showed that while most proposals passed, the first did not achieve the necessary majority. No new material events were disclosed.
  • Kamada (KMDA.TA) – Down 0.41 %, USD 7.73. Market cap: USD 448.8 million; P/E: 20.58.
  • Tat (TATT.TA) – Down 3.29 %, USD 31.52. Market cap: USD 420.9 million; P/E: 20.33.
  • Delta Galil (DELG.TA) – Up 2.29 %, ILS 181.6. Market cap: ILS 1.3 billion; P/E: 15.56.
  • Entera Bio (ENTX) – Down 0.98 %, USD 3.02. Market cap: USD 530.5 million.

Company Overview

Formula Systems 1985 Ltd., together with its subsidiaries and affiliates, delivers software consulting and computer‑based business solutions across a diversified client base that includes telecommunications, banking, insurance, public utilities, airports, travel, and retail. The firm was founded in 1985 and went public on 21 October 1997. Its services are marketed under the umbrella of Formula Systems and can be explored in depth on the company’s website, www.formula.co.il . The company remains listed on the Tel Aviv Stock Exchange, where it continues to attract investor attention with its robust performance metrics and expanding market reach.

This article presents a factual account of Formula’s recent trading activity and contextualizes its performance within the broader market environment.